CDKN2A and non-small cell lung carcinoma: Moreover, the pooled data of studies with multivariate analysis demonstrated the significant association between p16 hypermethylation and OS of NSCLC, suggesting that p16 hypermethylation might be an independent prognostic factor of poor survival in patients with NSCLC.